Brazilian study tracks Real-World impact of triple COPD inhaler
Disease control
Not yet recruiting
This study aims to see how well a triple-combination inhaler (Trimbow®) works for adults with severe COPD in real-world Brazilian clinics. It will follow about 400 patients for 6 months to measure changes in their breathing symptoms, lung function, and quality of life. The study …
Sponsor: Chiesi Farmaceutica Ltda. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC